Apyx Medical Corporation (APYX) — Stock Score Summary

Apyx Medical Corporation (APYX) has a MoatMap StockRank of 56/100 based on Quality (38/100), Value (39/100), and Momentum (64/100) factor scores. The current signal is HOLD. Apyx Medical is a small-cap medical technology company specializing in helium plasma cosmetic procedures. It is currently unprofitable, lacks scale, and does not align with any of our high-conviction macro themes.

Apyx Medical Corporation develops and commercializes advanced energy devices, with its flagship J-Plasma/Renuvion technology providing unique cold plasma energy for skin tightening and soft tissue coagulation in cosmetic and surgical applications. The company's competitive moat is centered on its proprietary J-Plasma technology, which offers differentiated clinical outcomes and has established a significant niche within the rapidly growing aesthetic and surgical markets. Apyx Medical is an innovator, leveraging its intellectual property to drive adoption in high-value medical procedures.

Key Financial Metrics

Price$4.86
Market Cap$174M
P/E (Forward)-16.34
Price/Book14.02
Return on Equity-76.5%
Return on Invested Capital-9.5%
Debt/Equity301.50
Gross Margin63.2%
Operating Margin-7.3%
Revenue Growth32.5%
Free Cash Flow$-8M

Apyx Medical Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Apyx Medical Corporation’s (APYX) StockRank?
MoatMap’s StockRank for Apyx Medical Corporation (APYX) is 56/100, with a Hold signal. It is a composite of Quality (38), Value (39), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Apyx Medical Corporation have an economic moat?
Apyx Medical Corporation (APYX) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Apyx Medical Corporation a buy, hold, or sell?
MoatMap’s current signal for Apyx Medical Corporation (APYX) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Apyx Medical Corporation in?
Apyx Medical Corporation (APYX) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksAPYX deep dive reportAI ChampionsHow we score stocksSense-check another stock